In my most recent post, I shared links to a number of articles and sites that provide information on cancer and coping with the COVID-19 pandemic.
Over the last two weeks, much more information has been published on a variety of sites to help inform those of us who are dealing with cancer in this difficult time.
Here are links to several more resources that seem especially helpful, along with a brief description of what’s covered in each.
These are stressful and uncertain times, as the world races to try to curtail the spread of the coronavirus and to develop a vaccine to prevent it.
While the crisis is overwhelmingly on our minds, cancer isn’t going away. Those currently dealing with cancer have no choice but to continue to deal with it in the best way possible right now.
In this post, I’m sharing links to a number of articles and sites that provide relevant information on cancer and coping with the COVID-19 pandemic. Continue reading
I remember how terrifying it was to hear the diagnosis of breast cancer. At the age of 35, I had to face a potentially life-threatening diagnosis, major surgery and chemotherapy after that.
If that wasn’t enough, what if I had woken up after my mastectomy only to discover that I had a bill for thousands of dollars that my insurance wouldn’t cover and I couldn’t pay?
Many women today are facing that very situation. Continue reading
When I read news articles about cancer research, I often find myself annoyed by the confusing way in which terminology about cancer and cancer research in used.
In cancer language, it’s not unusual for the medical or scientific meaning of a word to be different from the way the same word is understood in everyday language.
Two recent studies have come out with some interesting and important findings about exposures to endocrine disrupters and our risks for cancer.
One widely-reported study examined the risks for breast cancer associated with the use of hair dyes, which contain endocrine disrupters.
And another study looked at the way exposures to endocrine disrupters are measured. This study was not as widely publicized, but its findings could potentially be very significant. Continue reading
I always come back from the San Antonio Breast Cancer Symposium overflowing with information and insights about the latest developments in breast cancer research.
This year, we learned about fascinating research in areas such as matching treatments better to individuals based on the molecular characteristics of their cancer and finding more ways to bring immunotherapy into breast cancer treatment. Continue reading
Timely access to treatment is critical for individuals dealing with any number of medical conditions. Metastatic breast cancer is no exception.
The Metastatic Breast Cancer Access to Care Act would waive the lengthy waiting periods that currently prevent individuals with advanced breast cancer from receiving timely access to care. Continue reading
Over the years, October has become a marketing opportunity for companies that splash pink on their products, suggesting to consumers that they’re helping the breast cancer cause by buying these products.
Unfortunately, most of the time very little of the money paid for these products actually goes to breast cancer-related charities. Continue reading
One of the stories that has stood out over the last few years in breast cancer treatment was the FDA’s approval in 2015 of the drug palbociclib (Ibrance) for treatment of hormone receptor-positive metastatic breast cancer.
This year, there have been several new developments in targeted therapies for hormone-receptor positive breast cancer. Continue reading
I’m delighted to participate in the 2019 Summer Blogging Challenge offered by my friend and fellow blogger, Nancy, at Nancy’s Point.
The challenge involves answering a series of random questions about ourselves and blogging. Continue reading
